Monitoring for atrial fibrillation in discharged stroke and transient ischemic attack patients: a clinical and cost-effectiveness analysis and review of patient preferences

De Angelis G, Cimon K, Sinclair A, Farrah K, Cairns J, Baranchuk A, Cipriano LE, Akhtar AO, Weeks L, Rader T, Garland S
Record ID 32018002183
English
Original Title: Monitoring for atrial fibrillation in discharged stroke and transient ischemic attack patients
Authors' objectives: The aim of this health technology assessment (HTA) is to inform decision-making about the appropriate use of outpatient cardiac monitoring devices in patients who have experienced a stroke and/or TIA. Issues such as determining whether hospitals should adopt a policy of discharging stroke patients with outpatient cardiac monitoring devices, and determining which patients should be discharged with these devices, are in need of evidence-based support. This HTA addresses these issues by evaluating the clinical effectiveness and cost-effectiveness of cardiac monitoring devices in outpatient stroke and/or TIA patients. This HTA also identifies patient perspectives regarding the value and impact of outpatient cardiac monitoring devices for AF monitoring on their health, health care, and quality of life.
Details
Project Status: Completed
URL for project: https://cadth.ca/monitoring-atrial-fibrillation-discharged-stroke-and-transient-ischemic-attack-patients
URL for protocol: https://cadth.ca/sites/default/files/pdf/OP0523_AF_Screening_Protocol.pdf
Year Published: 2016
URL for published report: https://cadth.ca/sites/default/files/pdf/OP0523_AF_Screening_Report.pdf
URL for additional information: https://cadth.ca/monitoring-atrial-fibrillation-discharged-stroke-and-transient-ischemic-attack-patients
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Canada
Pubmed ID: 27227190
MeSH Terms
  • Atrial Fibrillation
  • Stroke
  • Ischemic Attack, Transient
  • Patient Participation
  • Monitoring, Ambulatory
  • Patient Discharge
  • Cost-Benefit Analysis
  • Electrocardiography, Ambulatory
Keywords
  • Atrial fibrillation
  • Stroke
  • Transient ischemic attack
  • Patient monitoring
  • Patient preferences
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: <p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.